As the Ministry of Health of the Slovak Republic publicly declared, it continues to prepare the draft amendment to the law on the scope and conditions for reimbursement of medicines. This week 17 main experts of the MZ SR discussed with representatives of the Ministry. The amendment aims to increase the availability of new medicines and advanced therapy medicinal products as well as to maintain the availability of the most frequently used medicinal products.
After the August round table with representatives of patient organisations, the discussion on the draft amendment of the drug law is continuing on the Slovak Ministry of Health before its entry into the legislative process. The opinion of experts and the constructive discussion with them is very important for the health sector in creating a law to help them treat their patients, Slovak Health Minister Kamil Šaško, represented at the meeting by State Secretary Ladislav Slobodník. He stressed that the purpose of the draft amendment to the law was to set clear and fair criteria for including medicines in the system as well as for maintaining those most frequently prescribed.
At the meeting 17 main experts of MZ SR for dermatovenerology, diabetes, endocrinology, haematology, clinical pharmacology, clinical immunology and allergology, clinical oncology, paediatric oncology, neurology, ophthalmology, organ transplantation, pediatrics, general care for children and adolescents, cardiology, pneumology and phtizeology, rheumatology and internal medicine discussed.
Ministry representatives also plan to discuss the draft law with the general public, health insurance representatives and pharmaceutical companies before the ordinary legislative process begins.